97 related articles for article (PubMed ID: 11145158)
1. Microbial transformation of kawain and methysticin.
Abourashed EA; Khan IA
Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):1996-8. PubMed ID: 11145158
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of some kava pyrones in the rat.
Rasmussen AK; Scheline RR; Solheim E; Hänsel R
Xenobiotica; 1979 Jan; 9(1):1-16. PubMed ID: 760318
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.
Mathews JM; Etheridge AS; Valentine JL; Black SR; Coleman DP; Patel P; So J; Burka LT
Drug Metab Dispos; 2005 Oct; 33(10):1555-63. PubMed ID: 16033948
[TBL] [Abstract][Full Text] [Related]
4. Kavalactone metabolism in the isolated perfused rat liver.
Fu S; Rowe A; Ramzan I
Phytother Res; 2012 Dec; 26(12):1813-6. PubMed ID: 22407838
[TBL] [Abstract][Full Text] [Related]
5. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents.
Backhauss C; Krieglstein J
Eur J Pharmacol; 1992 May; 215(2-3):265-9. PubMed ID: 1396990
[TBL] [Abstract][Full Text] [Related]
6. Superheated water chromatography-nuclear magnetic resonance spectroscopy of kava lactones.
Chienthavorn O; Smith RM; Wilson ID; Wright B; Lenz EM
Phytochem Anal; 2005; 16(3):217-21. PubMed ID: 15997856
[TBL] [Abstract][Full Text] [Related]
7. Microbial models of mammalian metabolism: microbial transformation of naproxen.
el Sayed KA
Pharmazie; 2000 Dec; 55(12):934-6. PubMed ID: 11189871
[TBL] [Abstract][Full Text] [Related]
8. In-vitro metabolism of the new anxiolytic agent, RWJ-50172, in rat hepatic S9 fraction and microbial transformation in fungi, Cunninghamella sp.
Wu WN; McKown LA; Melton JL; Reitz AB
J Pharm Pharmacol; 2003 Aug; 55(8):1099-105. PubMed ID: 12956899
[TBL] [Abstract][Full Text] [Related]
9. Microbial biotransformation of cryptotanshinone by Cunninghamella elegans and its application for metabolite identification in rat bile.
Sun JH; Yang M; Ma XC; Kang J; Han J; Guo DA
J Asian Nat Prod Res; 2009 Jun; 11(6):482-9. PubMed ID: 20183279
[TBL] [Abstract][Full Text] [Related]
10. Densitometric analysis of kawain in kava-kava root extracts.
Janeczko Z; Krzek J; Pilewski N; Walusiak D
Acta Pol Pharm; 2001; 58(6):463-8. PubMed ID: 12197620
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
[TBL] [Abstract][Full Text] [Related]
12. Effects of kawain and dihydromethysticin on field potential changes in the hippocampus.
Walden J; von Wegerer J; Winter U; Berger M; Grunze H
Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):697-706. PubMed ID: 9194150
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
Uebelhack R; Franke L; Schewe HJ
Pharmacopsychiatry; 1998 Sep; 31(5):187-92. PubMed ID: 9832350
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of doxepin by Cunninghamella elegans.
Moody JD; Freeman JP; Cerniglia CE
Drug Metab Dispos; 1999 Oct; 27(10):1157-64. PubMed ID: 10497142
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of metoprolol by the fungus Cunninghamella blakesleeana.
Ma B; Huang HH; Chen XY; Sun YM; Lin LH; Zhong DF
Acta Pharmacol Sin; 2007 Jul; 28(7):1067-74. PubMed ID: 17588344
[TBL] [Abstract][Full Text] [Related]
16. Microbial transformation of naproxen by Cunninghamella species.
Zhong DF; Sun L; Liu L; Huang HH
Acta Pharmacol Sin; 2003 May; 24(5):442-7. PubMed ID: 12740180
[TBL] [Abstract][Full Text] [Related]
17. Biotransformation of adrenosterone by filamentous fungus, Cunninghamella elegans.
Choudhary MI; Khan NT; Musharraf SG; Anjum S; Atta-Ur-Rahman
Steroids; 2007 Dec; 72(14):923-9. PubMed ID: 17889091
[TBL] [Abstract][Full Text] [Related]
18. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
[TBL] [Abstract][Full Text] [Related]
19. A microbial model of mammalian metabolism: biotransformation of 4,5-dimethoxyl-canthin-6-one using Cunninghamella blakesleeana CGMCC 3.970.
Fan HX; Zhou ZQ; Peng J; Wu BJ; Chen HR; Bao XF; Mu ZQ; Jiao WH; Yao XS; Gao H
Xenobiotica; 2017 Apr; 47(4):284-289. PubMed ID: 27237303
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
